LifeMine Therapeutics, Inc. — Form D
LifeMine Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-11. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-10-11
- Form: D
- Accession: 0001686955-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Remaining: $25K
- Investors: 1
- Date of first sale: 2016-09-23
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-272183
Issuer
- Name: LifeMine Therapeutics, Inc.
- CIK: 0001686955
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 100 Acorn Park, 6th Floor, Cambridge, MA, 02140
- Phone: 617-945-9510
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Hingge L Hsu | Director | Cambridge, MA |
| WeiQing L Zhou | Director | Boston, MA |
| Yanling L Cao | Director | Cambridge, MA |
| Richard L Klausner | Director | Cambridge, MA |
| Wei L Li | Director | Cambridge, MA |
| Krishna L Yeshwant | Director | Cambridge, MA |
| Jim L Tananbaum | Director | Cambridge, MA |
| Edward L Hu | Director | Cambridge, MA |
| Hingge L Hsu | Executive Officer | Cambridge, MA |
| Gregory L Verdine | Director | Cambridge, MA |
| Gregory L Verdine | Executive Officer | Cambridge, MA |
| WeiQing L Zhou | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More